AI Summary
This article discusses a fully synthetic TF-based self-adjuvanting vaccine that has been developed to trigger iNKT cells and Mincle, providing protection against tumor development in mice. The vaccine shows promising potential for cancer immunotherapy by activating these immune cells and boosting the immune response against tumors.